| Literature DB >> 34380501 |
Jiaxun Jiao1,2,3, Jiaqi Li1,3, Yun Luo1,3, Wei Zhang4,5.
Abstract
BACKGROUND: This retrospective study aimed to analyze the influence of Modic changes (MCs) on the clinical and radiographic outcomes of transforaminal lumbar interbody fusion with hybrid graft.Entities:
Keywords: Allogeneic freeze-dried bone graft; Autologous local bone graft; Fusion; Modic changes; Outcomes; Transforaminal lumbar interbody fusion
Mesh:
Year: 2021 PMID: 34380501 PMCID: PMC8356436 DOI: 10.1186/s13018-021-02652-7
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Sagittal T1-weighted (A) and T2-weighted (B) magnetic resonance images demonstrate L4−L5 lumbar disc herniation with MCs-0 signs. Postoperative radiographs (C) at the most recent follow-up confirming the solid fusion (D)
Fig. 2Sagittal T1-weighted (A) and T2-weighted (B) magnetic resonance images demonstrate L5−S1 lumbar disc herniation with MCs-1 signs. Postoperative radiographs (C) at the most recent follow-up confirming the solid fusion (D)
Fig. 3Sagittal T1-weighted (A) and T2-weighted (B) magnetic resonance images demonstrate L4−L5 lumbar disc herniation with MCs-2 signs. Postoperative radiographs (C) at the most recent follow-up confirming the solid fusion (D)
Fig. 4Lumbar lordosis (A): the angle between the upper endplate of L1 and the upper endplate of S1. Segmental lordosis (B): the angle subtended by the superior endplate line of the caudal vertebral body and the inferior endplate line of the cephalad vertebral body. Disc height: average of the anterior (C) and posterior (D) margins of the intervertebral space
Fig. 5Solid fusion was considered to be achieved in the presence of bridging bone between the endplates of the cephalad and caudal vertebral bodies
Demographic data of patients in the 3 groups
| MCs-0 group | MCs-1 group | MCs-2 group | ||
|---|---|---|---|---|
| Age (years) | 55.6 ± 8.6 | 56.3 ± 11.2 | 58.3 ± 7.8 | 0.216 |
| Gender (M/F) | 18/20 | 9/11 | 13/18 | 0.903 |
| BMI | 25.7 ± 8.5 | 26.7 ± 7.8 | 26.3 ± 8.1 | 0.805 |
| Smoking | 13/25 | 9/11 | 12/19 | 0.722 |
| Diagnosis | 0.758 | |||
| LDH | 15 | 11 | 13 | |
| LSS | 13 | 5 | 12 | |
| LS | 10 | 4 | 6 | |
| Surgical level | 0.760 | |||
| L3−L4 | 6 | 1 | 5 | |
| L4−L5 | 20 | 12 | 16 | |
| L5−S1 | 12 | 7 | 10 | |
| Cage subsidence | ||||
| Subsidence | 6 | 8 | 7 | 0.117 |
| No subsidence | 32 | 12 | 24 | |
| Blood Loss (mL) | 116.6 ± 21.1 | 120.8 ± 23.9 | 119.2 ± 19.5 | 0.172 |
| Operative time (min) | 79.6 ± 17.5 | 82.3 ± 20.8 | 80.5 ± 21.2 | 0.236 |
| Follow up (month) | 23.3 ± 3.8 | 22.4 ± 2.5 | 24.3 ± 5.6 | 0.372 |
CRP and ESR values before surgery through postoperative day 21
| Preoperative | Postoperative | |||||
|---|---|---|---|---|---|---|
| Day 1 | Day 3 | Day 7 | Day 15 | Day 21 | ||
| CRP level, mg/L | ||||||
| MCs-0 group | 1.9 ± 0.8 | 20.3 ± 5.5* | 58.2 ± 11.7* | 23.8 ± 9.7* | 8.6 ± 1.7* | 2.3 ± 1.9 |
| MCs-1 group | 2.2 ± 1.1 | 26.3 ± 73* | 66.3 ± 15.2* | 30.6 ± 10.1* | 10.7 ± 2.3* | 5.3 ± 1.5 |
| MCs-2 group | 2.1 ± 0.9 | 24.8 ± 8.6* | 62.9 ± 13.1* | 27.3 ± 8.2* | 9.3 ± 1.9* | 3.6 ± 2.1 |
| ESR, mm/h | ||||||
| MCs-0 group | 9.6 ± 2.5 | 19.5 ± 2.3* | 39.6 ± 7.1* | 46.6 ± 10.3* | 23.5 ± 5.7* | 11.3 ± 3.2 |
| MCs-1 group | 10.8 ± 3.1 | 22.5 ± 3.8* | 45.1 ± 8.6* | 56.1 ± 9.2* | 33.6 ± 6.8* | 15.6 ± 5.9 |
| MCs-2 group | 10.3 ± 2.6 | 20.3 ± 2.9* | 43.9 ± 5.8* | 52.8 ± 7.2* | 28.6 ± 7.1* | 13.2 ± 6.7 |
* Significant difference compared with the preoperative in each group.
Comparison of preoperative, postoperative and the final follow-up radiographic parameters in the 3 groups
| MCs-0 group | MCs-1 group | MCs-2 group | ||
|---|---|---|---|---|
| Preoperative | ||||
| DH (mm) | 9.7 ± 1.5 | 8.9 ± 2.1 | 8.7 ± 1.6 | 0.013 |
| LL (°) | 50.1 ± 9.5 | 49.6 ± 10.5 | 50.3 ± 10.5 | 0.631 |
| SL (°) | 16.3 ± 7.2 | 15.7 ± 6.2 | 15.8 ± 7.5 | 0.199 |
| Postoperative | ||||
| DH (mm) | 11.5 ± 1.9* | 11.3 ± 2.1* | 11.6 ± 1.7* | 0.484 |
| LL (°) | 54.3 ± 10.8* | 55.8 ± 11.3* | 54.5 ± 13.6* | 0.456 |
| SL (°) | 18.9 ± 6.3* | 18.2 ± 7.8* | 18.5 ± 8.3* | 0.601 |
| Final follow-up | ||||
| DH (mm) | 10.9 ± 2.1* | 9.7 ± 1.5* | 9.8 ± 1.6* | 0.027 |
| LL (°) | 53.5 ± 11.6* | 52.8 ± 13.3* | 52.8 ± 15.1* | 0.693 |
| SL (°) | 18.1 ± 7.5* | 17.3 ± 6.7* | 17.8 ± 8.7* | 0.436 |
* Significant difference compared with the preoperative in each group.
Comparison of preoperative, postoperative and final follow-up clinical outcomes in the 3 groups
| MCs-0 group | MCs-1 group | MCs-2 group | ||
|---|---|---|---|---|
| ODI | ||||
| Preoperative | 25.3 ± 8.8 | 26.7 ± 9.3 | 28.2 ± 8.5 | 0.257 |
| Final follow-up | 12.6 ± 10.3* | 8.8 ± 10.3* | 13.6 ± 9.8* | 0.459 |
| VAS for low back pain | ||||
| Preoperative | 6.4 ± 2.7 | 7.6 ± 2.5 | 6.9 ± 3.2 | 0.153 |
| Final follow-up | 2.6 ± 1.9* | 1.6 ± 1.5* | 2.5 ± 1.7* | 0.031 |
| VAS for leg pain | ||||
| Preoperative | 6.3 ± 2.8 | 6.2 ± 3.6 | 6.0 ± 2.2 | 0.582 |
| Final follow-up | 2.3 ± 2.1* | 2.1 ± 1.9* | 2.7 ± 1.9* | 0.183 |
* Significant difference compared with the preoperative in each group.